Edity Streutman - Novolog Pharm VP System

NVLG Stock   169.90  0.50  0.30%   

Insider

Edity Streutman is VP System of Novolog Pharm Up 1966
Age 61
Phone972 8 660 4400
Webhttps://www.novolog.co.il

Novolog Pharm Management Efficiency

The company has return on total asset (ROA) of 0.0174 % which means that it generated a profit of $0.0174 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.106 %, meaning that it generated $0.106 on every $100 dollars invested by stockholders. Novolog Pharm's management efficiency ratios could be used to measure how well Novolog Pharm manages its routine affairs as well as how well it operates its assets and liabilities.
Novolog Pharm Up 1966 has accumulated 916 K in total debt with debt to equity ratio (D/E) of 0.6, which is about average as compared to similar companies. Novolog Pharm Up has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Novolog Pharm until it has trouble settling it off, either with new capital or with free cash flow. So, Novolog Pharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Novolog Pharm Up sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Novolog to invest in growth at high rates of return. When we think about Novolog Pharm's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Nirit ZeeviAzrieli Group
44
Rafi AttiasTadiran Hldg
57
Naftali SternlichtBezeq Israeli Telecommunication
N/A
Yair HoreshAzrieli Group
51
Ronnie KennethNova
62
Thomas LarsonNova
N/A
Moshe MamrodTadiran Hldg
71
Michael AvidanEnlight Renewable Energy
N/A
Ofer YaromAzrieli Group
N/A
Nir YehudaEnlight Renewable Energy
69
Ayelet IsraeliEnlight Renewable Energy
N/A
Meron CarrEnlight Renewable Energy
50
Moran MamdorLeviadTadiran Hldg
41
Zvika AbramovichBezeq Israeli Telecommunication
N/A
Amit KurlandBezeq Israeli Telecommunication
52
Tobi FischbeinBezeq Israeli Telecommunication
50
Meni BaruchBezeq Israeli Telecommunication
48
Avi ZamirTadiran Hldg
65
Daniel VakninTadiran Hldg
57
Shfi BessenTadiran Hldg
50
Eyal HenkinAzrieli Group
54
Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange. Novolog Pharm Up 1966 (NVLG) is traded on Tel Aviv Stock Exchange in Israel and employs 900 people.

Management Performance

Novolog Pharm Up Leadership Team

Elected by the shareholders, the Novolog Pharm's board of directors comprises two types of representatives: Novolog Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novolog. The board's role is to monitor Novolog Pharm's management team and ensure that shareholders' interests are well served. Novolog Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novolog Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
Maoz Ramon, Chief Ltd
David Shmuelov, Chief Company
Rafi Friedman, CEO of a Subsidiary
Eran Taus, Chief Officer
Armin Shaun, Chief Ltd
Amir Shachar, Chief Officer
Amitai Gridish, Chief Ltd
Eli Dahan, Advisor CEO
Assaf Vardi, Vice President - Business Development, Sales & Marketing
Edity Streutman, VP System

Novolog Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novolog Pharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Novolog Stock

Novolog Pharm financial ratios help investors to determine whether Novolog Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novolog with respect to the benefits of owning Novolog Pharm security.